In highly trained male volleyball athletes, short-term POMj did not outperform placebo on group-mean recovery outcomes at 48 h post-EIMD; however, SWC-based analyses showed a higher proportion of meaningful responders with POMj in selected high-velocity isokinetic measures, supporting responder-focused evaluations of recovery nutraceuticals in sport-specific settings.
Rezaei et al. (Tue,) studied this question.